Keane, Fergus
Park, Wungki
O’Reilly, Eileen M.
Funding for this research was provided by:
National Cancer Institute (P30 CA008478)
Article History
Accepted: 23 May 2022
First Online: 25 June 2022
Declarations
:
: FK: No disclosures.WP: Research funding to institution: Merck, Astellas, Gossamerbio,Consulting: Aegle, Onconics.EMO’R: Research funding to institution: Genentech-Roche, Celgene-BMS, BioNTech, AstraZeneca, Silenseed, Arcus, Elicio, Parker Institute.Consulting/Advisory/DSMB: Cytomx Therapeutics (DSMB), Cend Therapeutics, Ipsen, Merck, IDEAYA, Noxxon, Rafael Therapeutics (DSMB), Seagen, Boehringer Ingelheim, AstraZeneca, Thetis, Biosapien; Agios (spouse), Genentech-Roche (spouse), Eisai (spouse).